PRUDENTIAL PLC (PUK): what the price assumes

In the published model solve dated 2026-Q2, anchored at $27.65, PRUDENTIAL PLC (PUK) is priced for 17.1% return on equity. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-08-08.

Generated: 2026-08-30 · Source: https://boothcheck.com/report/PUK

Headline

FieldValue
TickerPUK
CompanyPRUDENTIAL PLC
Sector / IndustryFinancial Services
Current price$27.65/sh
CompositionHong Kong 37% / Indonesia 7% / Malaysia 9% / Singapore 24% / Growth markets and other 20% / Eastspring 3%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basisfinancials
Return on equity needed17.1%
Return on equity now19.8%
ROE gap-2.7pp
Price-to-book1.77x

Solve inputs: computed at a 11.4% cost of equity with 4% terminal growth over a 10-year stage, on common book equity (FY2025).

How unusual the bet is: within-range

ReferenceValue
vs own history+1.02σ
cohort percentile (of 79 peers)49
sustained it ~10 years at this level55%
implied end-window share0%

Valuation X-Ray

The price is supported by asset-based and earnings-power value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset0.79x3justifies
Earnings0.83x1justifies
Relative0
Growth0

Families that justify the price: Asset, Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 5.3%); the inversion above states its own rate.

Per-Model Detail (n=4)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowthno
Bank Fair Value (P/TBV)$53.960.51xyesTBVPS $16.06 × 3.36x (ROE (TTM) 19.3% / CoE 9.3%, g=5.0% (sustainable: 65% retention × ROE, 5% cap; not the terminal-growth assumption))
Relative ValuationRelativenoP/E 11x (static sector reference · 2026-04), scenarios: 9.3x / 11.0x / 12.6x (bear / base = reference held flat / bull), EV/EBITDA 17.99x
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$34.950.79xyesBV/sh $16.76, ROE (TTM) 19.3%, ke 9.3%
Two-Stage Excess ReturnAsset$49.890.55xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowthnoRev $11.5B, growth -10% (input: historical growth; tapered), Terminal P/S: 2.6x / 3.1x / 3.5x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelativenoEPS $3.08, growth 1% (input: historical EPS growth), PEG=7.77 (Overvalued)
Margin TrajectoryGrowthno
Earnings Power ValueEarningsno
Residual IncomeAssetno
Graham NumberAsset$34.110.81xyes√(22.5 × EPS $3.08 × BVPS $16.76) — Graham's conservative floor
EV/EBITDA RelativeRelativeno
FCF YieldEarningsno
SBC-Adj FCF YieldEarningsno
Ben Graham FormulaEarningsnoEPS $3.08 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAssetno
P/Sales SectorRelativeno
PEG Fair ValueRelativenoEPS $3.08 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings YieldEarnings$33.340.83xyesEPS $3.08 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Economic-Unit Decomposition (Sum Of The Parts)

The issuer is a funded financial business. Debt, interest, and cash flows are operating inputs, so industrial EV, net-debt, WACC, and free-cash-flow lenses do not apply; value the common-equity claim with book, earnings, capital, and payout economics.

UnitRoleValuation basisRevenueReported profitValue evidenceStatus
Growth markets and otherfinancialequity4.0B reported-currencywithheldunresolved standalone equity facts required
Eastspringfinancialequity0.5B reported-currencywithheldunresolved standalone equity facts required

No unit-level total common-equity value is stated. Each financial unit requires supported standalone common equity, normalized earnings, capital adequacy, and payout capacity. Consolidated debt, interest, and cash are operating balances, not an enterprise-to-equity bridge; company-level book, earnings, capital, and payout lenses remain the coherent cross-checks.

Solvency

FieldValue
Share count CAGR (buyback)-0.5%

Deposit/float-funded balance sheet: debt is funding, not corporate leverage, and GAAP operating cash flow follows loan flows. Net-debt, interest-coverage, and cash-burn lenses do not apply. The solvency frame for a financial is regulatory capital and payout capacity (CET1, stress buffer, dividends plus buybacks against earnings).

Bullet Takeaways

Bull Case

Life insurance is one of the few industries where the profit on a sale arrives over the following decades rather than the following quarter. That makes reported earnings a poor guide to what an insurer just did, and it moves the interesting number to the front of the process: how much new business was written, and at what margin. On that measure Prudential is having a good run. New business profit in the first quarter of 2026 came to 686 million dollars, up 10 per cent on the year, on sales of 1,823 million dollars and a margin two percentage points wider than the same quarter of 2025.

The part that is hard to copy is not the product. It is the distribution. Prudential sells through an agency force and through bank partnerships, and the 20-F is unusually direct about which of those it regards as the asset: Our agency channel remains central to the Group's growth strategy and is a significant competitive advantage. An agency force is expensive and slow to build, it takes years to reach productivity, and it cannot be bought off a shelf by a competitor who decides next year that Malaysia looks interesting. Bancassurance adds reach the agents cannot cover on their own. Both channels grew new business profit in the first quarter.

Where that machine is pointed matters as much as how well it runs. The segment mix is Hong Kong, Indonesia, Malaysia, Singapore, Growth markets and other, and the Eastspring asset manager, and behind it sits a structural gap the company sizes in its own filing: a Mainland China health protection shortfall it puts above 140 billion dollars. In Singapore the company states that We continue to lead the market in terms of health new business, and we now have a comprehensive range of products for the high-net-worth segment across our channels, and Singapore profit after tax of 966 million dollars in 2025 was 71 per cent higher than the prior year. Selling protection into markets that are underinsured is a slower business than selling savings products into rich ones. It is also a more durable one, because the customer's reason to buy does not depend on where interest rates went.

Capital discipline has caught up with the growth, which was not always true of this company. Prudential runs to a stated capital target, We seek to operate with a free surplus ratio of between 175 per cent and 200 per cent, and it has been handing back what sits above the range. Capital returned to shareholders reached 1.8 billion dollars in 2025 against 1.4 billion in 2024, of which the buyback programme accounted for 1,211 million against 785 million a year earlier. The policy behind the ordinary distribution is deliberately tied to what the business actually generates: Our dividend policy remains to grow broadly in line with net operating free surplus generation. That is a company paying out of surplus rather than out of optimism.

Set against all of this, the price is not asking for heroics. Prudential changes hands near 1.8 times its book, and the return that multiple leans on is somewhat lower than the return it has recently been earning. Three separate asset-based lenses, the ones that value a financial on its capital and the excess return it earns on that capital, land above where the shares trade. So does a single earnings-power read. The growth and peer-multiple lenses produced nothing usable at all, which is its own kind of information: whatever this is, it is not a growth story that needs the next decade to go perfectly.

Bear Case

The variable with the most leverage on this business is not underwriting. It is the political and regulatory weather across a handful of Asian jurisdictions, and Hong Kong alone is 37 per cent of the mix. A meaningful share of what is sold there is bought by visitors from the Mainland, a cross-border flow that exists because policy permits it. The company describes that demand confidently, saying We are confident in the continuation of the underlying drivers of demand from both the domestic and Mainland China visitors segments and for sustained quality growth for the Hong Kong segment. Confidence is not control. The Mainland operation itself is not even wholly owned: CITIC-Prudential Life Insurance Company, the Group's Mainland China segment, is a joint venture with the CITIC Group in which the Group owns a 50 per cent interest. The structurally fastest-growing market in the portfolio is one the company shares with a state-linked partner. And the risk section lists, among the things that could disrupt the whole enterprise, An increase in military tensions, regional hostilities or new conflicts which may disrupt business operations, investments, market confidence and expectations and growth.

Now the arithmetic the price rests on. Buying the shares near 1.8 times book is a bet that the company keeps generating a return on equity somewhere around 17.4 per cent. It has recently been earning about 19.8 per cent, which looks like room to spare until you ask what that number is made of. In 2025 Hong Kong profit after tax was 1,333 million dollars, up 57 per cent, while Hong Kong adjusted operating profit was 1,219 million dollars, up 14 per cent. The same business, the same year, two growth rates a factor of four apart. The gap is investment and market movement, not policies sold. Singapore shows the same shape. Strip the market contribution out and the cushion between what the company earns and what the shares require gets thin fast. Sustaining that kind of return is also rarer than it sounds: of firms that have reached it, only about 55 per cent were still there a decade later. Should the return settle back toward the middle of the range, the multiple of book the market pays compresses with it, and book value is the anchor here, so there is nowhere else for the adjustment to land.

Competition is not an abstraction in these markets either. The 20-F sets out what the fight is actually over, stating that The principal competitive factors affecting the sale of Prudential's products in its chosen markets are price and yields, financial strength and ratings, commission levels, product range, and brand. Three of those five are things a well-capitalised rival can simply buy. Bancassurance sharpens the point: the distribution runs through partner banks, and partnership economics get renegotiated on the bank's schedule, not the insurer's. Growth that arrives through somebody else's branch network is growth with a landlord.

There is also a gap between the capital-return story and what shareholders have actually received per share. The dollars are real. The dilution is too. Ordinary shares outstanding have fallen by roughly half a per cent a year since the end of 2021, because scrip dividends issue new shares back into the register even as the buyback retires them. The buyback itself is young: 785 million dollars in 2024, then 1,211 million in 2025, which is two years of retirement working against a register that scrip keeps topping up. A holder who reads 1.8 billion dollars of capital return and expects a matching shrinkage in the share count has not read the two lines together.

Regulation is the quiet cost. Mainland China's C-ROSS Phase II capital regime took effect in 2022 and reset how local capital is measured. On top of that sit five separate disclosure regimes moving at once, with the company noting that The pace and volume of sustainability-related regulatory changes, including ESG and climate-related changes, are also increasing. None of this shows up as a line item. It shows up as expense, and as the constant possibility that a capital rule somewhere moves the free surplus the dividend policy is pegged to.

Valuation

An insurer is worth the return it earns on the capital it holds, which is why the shares are read off book value rather than off an operating multiple. Prudential trades around 1.8 times its book equity. Turn that round and the market is assuming the company sustains a return on equity of roughly 17.4 per cent, indefinitely, on capital it keeps reinvesting.

That assumption sits below what the company has recently been earning, about 19.8 per cent, which is the unusual part. Most of what this framework looks at requires the business to improve. This one requires it to do slightly less well than it just did. The catch is in the composition of the recent figure rather than in the figure itself. Hong Kong profit after tax rose 57 per cent in 2025 while the adjusted operating profit for the same segment rose 14 per cent, and the difference is market movement running through the accounts. Judge the business on the operating measure and the gap between what is earned and what is assumed narrows considerably. The assumption also sits close to the upper edge of what the company's own record will carry, so it is not a soft target dressed as a demanding one.

The methods disagree in a specific and readable way. Three asset-based lenses, which value the capital base and the excess return earned on it, all land above the price. One earnings-power read does the same. The forward-growth and peer-multiple lenses produced no usable result. One earnings method is a single opinion rather than a chorus, so the weight sits with the asset-based group, and the pattern they make is the one you get from a value read rather than a growth bet: the shares are supported by what the balance sheet and the current earning power are worth, not by a future the static methods cannot frame.

The comparison set is where the reading gets awkward. The names Prudential is measured against are US-listed insurance groups doing structurally different work, and their growth reflects it: UNM grew revenue 3.4 per cent over the trailing year and WRB 4.3 per cent, while FNF managed 14.0 per cent on title insurance and EQH went backwards. Prudential's own top-line growth comes from underpenetrated markets rather than from mature US lines, and the accounting standards behind the two sets of figures are not the same, so the multiple comparison carries more caution than the growth comparison does. Against that group the price-to-book sits in the lower half.

For a life insurer the balance-sheet question is capital adequacy and payout capacity, not corporate borrowing, because the liabilities are policies rather than lenders. Prudential holds about 20.1 billion dollars of shareholders' equity under IFRS, runs to a stated free surplus ratio of 175 to 200 per cent, and returned 1.8 billion dollars to shareholders in 2025 against 1.4 billion the year before. Capital return of that shape is discretionary and can be switched off in a bad year, which is exactly what makes it a fair test of how comfortable management feels about the surplus.

Catalysts

The most recent operating data point is the first-quarter update published on 29 April 2026. New business profit came in at 686 million dollars, up 10 per cent on a constant-currency basis, with sales of 1,823 million dollars and a new business margin of 38 per cent, two points better than a year earlier. Hong Kong, Mainland China and Malaysia each grew new business profit by double digits. The Mainland joint venture was the notable qualification: management said the deliberate shift toward participating business moderated its margins, which is a mix decision rather than a demand problem, but it does mean the fastest-growing unit is currently trading margin for volume. Chief executive Anil Wadhwani closed the release with a target rather than a hope, saying We remain confident in delivering double-digit growth across our key financial metrics in 2026 and achieving our 2027 financial objectives.

The buyback is running continuously and is visible in real time. Under an arrangement with JP Morgan Securities announced on 6 January 2026 and authorised at the 2025 annual meeting, the company has been repurchasing on the order of 270,000 ordinary shares on each London trading day, with late-July purchases struck between 10.72 and 11.37 pounds a share. That is a mechanical, disclosed programme rather than an announced intention, and its continuation is the cleanest available read on whether the free surplus ratio is still running above the target band.

The half-year report is the next event that can move the analytical picture, because it is the first point at which the operating profit measure, rather than quarterly sales, gets updated. Two things are worth reading closely when it lands: whether the first quarter's margin expansion survived a second quarter, and whether the gap between profit after tax and adjusted operating profit narrows. The 2027 financial objectives management restated in April are the frame the market will grade that report against.

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

FY2025 20-F · Q1 2026 business performance update, 29 April 2026 · 6-K transaction in own shares, 3 August 2026

View the full interactive PUK report on boothcheck